Description
PHARMACEUTICAL DRUGS: BIOLOGICAL PRODUCT: IVIG GAMMAGARD
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-12-14+$6,919= $6,919
- Mod P000012014-04-24+$12,109= $19,028
- Mod P000022014-08-28+$57,816= $76,844
- Mod P000032015-05-07-$9,957= $66,887
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-12-14 | +$6,919 | $6,919 | PHARMACEUTICAL DRUGS: BIOLOGICAL PRODUCT: IVIG GAMMAGARD |
| Mod P00001· FUNDING ONLY ACTION | 2014-04-24 | +$12,109 | $19,028 | PHARMACEUTICAL DRUGS: BIOLOGICAL PRODUCT: IVIG GAMMAGARD |
| Mod P00002· FUNDING ONLY ACTION | 2014-08-28 | +$57,816 | $76,844 | PHARMACEUTICAL DRUGS: BIOLOGICAL PRODUCT: IVIG GAMMAGARD |
| Mod P00003· FUNDING ONLY ACTION | 2015-05-07 | −$9,957 | $66,887 | PHARMACEUTICAL DRUGS: BIOLOGICAL PRODUCT: IVIG GAMMAGARD |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M986PPZNJ8M8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026P0671 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $18,262 | FY2026 |
| 36C24826P1019 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C26226P1217 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24225P0537 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C25024P0468 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $25,200 | FY2024 |
| 36C25723P0156 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $3,434 | FY2023 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26216J3405 | SANOFI VACCINES US INC. | 262-NETWORK CONTRACT OFFICE 22 | $209,679 | FY2016 |
| VA26216P3483 | JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 262-NETWORK CONTRACT OFFICE 22 | $14,960 | FY2016 |
| VA26216E3967 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $20,913,958 | FY2016 |
| VA26216P2987 | PETNET SOLUTIONS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $58,136 | FY2016 |
| VA26216E3446 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $11,612,703 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26214P1689_3600_-NONE-_-NONE- · retrieved 2026-09-26.